News & Updates

Consumption of fresh or pasteurized sauerkraut both delivers a modest impact on blood pressure (BP) in healthy individuals, suggesting that pasteurization does not remove the physiological impact of this fermented food, reveals a study.

A study in Chile has noted the presence of elevated haemoglobin (Hb) among pregnant women despite the increased prevalence of depleted iron stores, contributing to adverse maternal outcomes.

In patients with locally advanced or metastatic urothelial cancer, enfortumab vedotin (EV)-induced cutaneous adverse events (cAEs) are associated with improved survival outcomes, according to a retrospective study.

New drug applications approved by US FDA as of 16-31 August 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

An editorial piece published in Hong Kong Medical Journal makes a case for universal access to noninvasive prenatal screening (NIPS) as the first-line screening option within Hong Kong’s public healthcare system – on the basis of women’s preferences and its clinical superiority vs first-trimester combined screening (FTS). [Hong Kong Med J 2026;32:287-290]

Treatment with interleukin (IL)-17 inhibitors in patients with hidradenitis suppurativa does not appear to contribute to an increase in the risk of inflammatory bowel disease (IBD), according to a meta-analysis.

A high positivity rate of antiparietal cell antibody (APCA) is seen among symptomatic patients from South and Southeast Asia, but only a few have severe predominant corpus atrophy or positive pepsinogen tests, reports a study. This finding suggests a low rate of autoimmune gastritis (AIG) in this population.

Letermovir prophylaxis falls short of reducing medication regimen complexity index (MRCI) over time in patients who underwent allogeneic haematopoietic stem cell transplantation (allo-HCT), according to a study.

Patients with ovarian cancer are no strangers to several drug therapy problems (DTPs), particularly adverse drug reactions, suggests a study.

The survival benefit associated with the use of statins in adults treated for colorectal cancer (CRC) is only modest at best, according to a target trial emulation.